SCHEMBL6448288

SCHEMBL6448288

O=C(Oc1ccccc1Br)[C@@]1(C(F)(F)F)CO1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.40
CNR1 P21554 1/20 0.36
POLB P06746 2/20 0.35
SMN1; SMN2 Q16637 5/20 0.34
HPGD P15428 3/20 0.34
KMT2A Q03164 3/20 0.34
PDK2 Q15119 2/20 0.34
LMNA P02545 2/20 0.34
GRM4 Q14833 1/20 0.34
PDK1 Q15118 1/20 0.34
PDK3 Q15120 1/20 0.34
PDK4 Q16654 1/20 0.34
HTT P42858 1/20 0.34
KDM4E B2RXH2 4/20 0.33
ALDH1A1 P00352 4/20 0.33
NPC1 O15118 3/20 0.32
RAB9A P51151 3/20 0.32
USP2 O75604 2/20 0.32
TSHR P16473 1/20 0.32
MEN1 O00255 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6448295 1.00 L3MBTL1 (0.40) L3MBTL1CNR1POLBSMN1; SMN2HPGD
SCHEMBL6448101 0.84 ALDH1A1 (0.40) L3MBTL1SMN1; SMN2HPGDKMT2AALDH1A1
SCHEMBL6448096 0.84 ALDH1A1 (0.40) L3MBTL1SMN1; SMN2HPGDKMT2AALDH1A1
SCHEMBL6450358 0.83 PDK2 (0.40) L3MBTL1POLBSMN1; SMN2KMT2APDK2
SCHEMBL6446835 0.83 HCRTR2 (0.39) POLBSMN1; SMN2HPGDKMT2APDK2
SCHEMBL6446836 0.83 HCRTR2 (0.39) POLBSMN1; SMN2HPGDKMT2APDK2
SCHEMBL6450356 0.83 PDK2 (0.40) L3MBTL1POLBSMN1; SMN2KMT2APDK2
SCHEMBL6450053 0.79 L3MBTL1 (0.42) L3MBTL1POLBSMN1; SMN2HPGDKDM4E
SCHEMBL6450044 0.79 L3MBTL1 (0.42) L3MBTL1POLBSMN1; SMN2HPGDKDM4E
SCHEMBL6450387 0.79 L3MBTL1 (0.42) L3MBTL1POLBSMN1; SMN2HPGDKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6921832-B2 Optically active fluorine-containing compounds and processes for their production TOSOH CORPORATION (JP) 2005-07-26 US disclosed
US-20040147756-A1 Optically active fluorine-containing compounds and processes for their production TOSOH CORPORATION (JP) 2004-07-29 US disclosed
EP-1422226-A1 Optically active fluorine-containing compounds and processes for their production Tosoh Corporation (JP) 2004-05-26 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040147756-A1 Optically active fluorine-containing compounds and processes for their production CYP2C19, CYP2F1, CYP2B6 L3MBTL1 1711/4885CNR1 3294/4885POLB 1140/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.